Tech Company Financing Transactions
iRhythm Technologies Funding Round
iRhythm Technologies, operating out of San Francisco, raised $17 million in investment from Novo Ventures and Norwest Venture Partners.
Transaction Overview
Company Name
Announced On
5/22/2014
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series E
Investors
Novo Ventures (Lead Investor) (Tiba Aynechi)
Norwest Venture Partners (Casper de Clercq)
Proceeds Purpose
The company will use the proceeds to further accelerate market growth for its ZIO Service, expand technology development and continue to establish clinical evidence supporting its flagship solution.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
650 Townsend St. 500
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Website
Email Address
Overview
iRhythm's goal is to reduce healthcare costs and improve arrhythmia detection, characterization and diagnosis by providing simple, seamless integration of heart rhythm data from client to cloud to clinician. Offering services like the ZIO Service to analyze heart beats has lead to the largest cardiac rhythm database in the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin King
Chief Financial Officer
Matthew Garrett
Executive Vice President
Mark Topash
VP - Customer Service
Allan Wilsker
VP - Human Resources
Kaja Odegard
VP - Operations
Judy Lenane
VP - R & D
Mark Day
VP - Sales
David Vort
Browse more venture capital transactions:
Prev: 5/22/2014: Storehouse venture capital transaction
Next: 5/23/2014: DoorDash venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs